A exciting therapy, retatrutide, is creating significant buzz within the healthcare community as a potential answer for stubborn weight problems. This unique drug, a dual agonist targeting glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, appears to exhibit impressive effi